Tumor Specific Delivery and Therapy by Double-Targeted Nanostructured Lipid Carriers with Anti-VEGFR-2 Antibody

Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations

Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,116 · see citing works

Nanomedicine: current status and future prospects

Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029 · see citing works

Tumor angiogenesis: past, present and the near future

Kerbel, R. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.505 · Cited by 973 · see citing works

Application of Nanotechnology in Cancer Therapy and Imaging

Wang, X., Yang, L., Chen, Z., & Shin, D. M. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0003 · Cited by 696 · see citing works

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G 1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2

Spratlin, J. L., Cohen, R. B., Eadens, M., Gore, L., Camidge, D. R., Diab, S., Leong, S., O’Bryant, C. L., Chow, L. Q. M., Serkova, N. J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7537 · Cited by 551 · see citing works

Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis

Murphy, E. A., Majeti, B. K., Barnes, L. A., Makale, M., Weis, S. M., Lutu-Fuga, K. M., Wrasidlo, W., & Cheresh, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803728105 · Cited by 454 · see citing works

Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1☆

Nakatsu, M. N., Sainson, R. C. A., Aoto, J. N., Taylor, K. L., Aitkenhead, M., Pérez‐del‐Pulgar, S., Carpenter, P. M., & Hughes, C. C. W. (2003) · Microvascular Research · doi:10.1016/s0026-2862(03)00045-1 · Cited by 451 · see citing works

Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2.

Kunkel, P., Ulbricht, U., Böhlen, P., Brockmann, M. A., Fillbrandt, R., Stavrou, D., Westphal, M., & Lamszus, K. (2001) · PubMed · Cited by 398 · see citing works

Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide

Dharap, S. S., Wang, Y., Chandna, P., Khandare, J. J., Qiu, B., Gunaseelan, S., Sinko, P. J., Stein, S., Farmanfarmaian, A., & Minko, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504274102 · Cited by 340 · see citing works

Poly (N-vinylpyrrolidone)-block-poly (D, L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation

Le Garrec, D., Gori, S., Luo, L., Lessard, D., Smith, D. C., Yessine, M.-A., Ranger, M., & Leroux, J.-C. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.018 · Cited by 255 · see citing works

The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor AZD6244 (ARRY-142886) Induces Growth Arrest in Melanoma Cells and Tumor Regression When Combined with Docetaxel

Haass, N. K., Sproesser, K., Nguyen, T. K., Contractor, R., Medina, C. A., Nathanson, K. L., Herlyn, M., & Smalley, K. S. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1440 · Cited by 241 · see citing works

Targeting Liposomal Chemotherapy via Both Tumor Cell–Specific and Tumor Vasculature–Specific Ligands Potentiates Therapeutic Efficacy

Pastorino, F., Brignole, C., Paolo, D. D., Nico, B., Pezzolo, A., Marimpietri, D., Pagnan, G., Piccardi, F., Cilli, M., Longhi, R., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2117 · Cited by 233 · see citing works

Lipid Nanoparticles: Effect on Bioavailability and Pharmacokinetic Changes

Souto, E. B., & Müller, R. H. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00477-3_4 · Cited by 212 · see citing works

Cyclic RGD Peptide-Conjugated Polyplex Micelles as a Targetable Gene Delivery System Directed to Cells Possessing αvβ3 and αvβ5 Integrins

Oba, M., Fukushima, S., Kanayama, N., Aoyagi, K., Nishiyama, N., Koyama, H., & Kataoka, K. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0700133 · Cited by 197 · see citing works

Monoclonal antibodies in the treatment of metastatic colorectal cancer: A review

Tol, J., & Punt, C. J. A. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.03.012 · Cited by 175 · see citing works

Nonpharmacologic Strategies for Managing Common Chemotherapy Adverse Effects: A Systematic Review

Lotfi‐Jam, K., Carey, M. L., Jefford, M., Schofield, P. E., Charleson, C., & Aranda, S. K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9053 · Cited by 169 · see citing works

A Bacterial Protein Enhances the Release and Efficacy of Liposomal Cancer Drugs

Cheong, I., Huang, X., Bettegowda, C., Diaz, L. A., Kinzler, K. W., Zhou, S., & Vogelstein, B. (2006) · Science · doi:10.1126/science.1130651 · Cited by 168 · see citing works

Nanostructured lipid carrier-based hydrogel formulations for drug delivery: A comprehensive review

Doktorovová, S., & Souto, E. B. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240802712590 · Cited by 158 · see citing works

In vitro and in vivo studies of a VEGF 121 /rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors

Veenendaal, L. M., Jin, H., Ran, S., Cheung, L. H., Navone, N. M., Marks, J. W., Waltenberger, J. L., Thorpe, P. E., & Rosenblum, M. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122157899 · Cited by 142 · see citing works

Paclitaxel and docetaxel in the treatment of breast cancer

Saloustros, E. S., Mavroudis, D., & Georgoulias, V. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.15.2603 · Cited by 129 · see citing works

Tumor Angiogenesis: Cause or Consequence of Cancer?

Shchors, K., & Evan, G. I. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2053 · Cited by 127 · see citing works

Synchronous selection of homing peptides for multiple tissues byin vivophage display

Kolonin, M. G., Sun, J. D., Do, K.-A., Vidal, C. I., Ji, Y., Baggerly, K., Pasqualini, R., Amp, W., Kolonin, M. G., Sun, J. D., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5186fje · Cited by 125 · see citing works

Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3

Tanno, S., Ohsaki, Y., Nakanishi, K., Toyoshima, E., & Kikuchi, K. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.03.006 · Cited by 123 · see citing works

Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer

Milane, L. S., Duan, Z., & Amiji, M. M. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.12.009 · Cited by 116 · see citing works

Lipid nanocapsules: Ready-to-use nanovectors for the aerosol delivery of paclitaxel

Hureaux, J., Lagarce, F., Gagnadoux, F., Vecellio, L., Clavreul, A., Roger, E., Kempf, M., Racineux, J.-L., Diot, P., & Benoît, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.013 · Cited by 100 · see citing works

Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel

Yanasarn, N., Sloat, B. R., & Cui, Z. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.004 · Cited by 95 · see citing works

Receptor-Targeted Liposomal Delivery of Boron-Containing Cholesterol Mimics for Boron Neutron Capture Therapy (BNCT)

Thirumamagal, B. T. S., Zhao, X. B., Bandyopadhyaya, A. K., Narayanasamy, S., Johnsamuel, J., Tiwari, R., Golightly, D. W., Patel, V., Jehning, B. T., Backer, M. V., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060075d · Cited by 72 · see citing works

Isoaspartate-Glycine-Arginine: A New Tumor Vasculature–Targeting Motif

Curnis, F., Sacchi, A., Gasparri, A. M., Longhi, R., Bachi, A., Doglioni, C., Bordignon, C., Traversari, C., Rizzardi, G., & Corti, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1272 · Cited by 71 · see citing works

Study on docetaxel-loaded nanoparticles with high antitumor efficacy against malignant melanoma

Zheng, D., Li, X., Xu, H., Lu, X., Hu, Y., & Fan, W. (2009) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmp045 · Cited by 62 · see citing works

Docetaxel in the treatment of advanced non-small-cell lung cancer

Saloustros, E. S., & Georgoulias, V. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.8.1207 · Cited by 51 · see citing works

Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven

Dings, R. P. M., Laar, E. S. V., Webber, J., Zhang, Y., Griffin, R. J., Waters, S. J., MacDonald, J. R., & Mayo, K. H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.048 · Cited by 48 · see citing works

In vivoanti-tumor efficacy of docetaxel-loaded thermally responsive nanohydrogel

Zhang, J., Qian, Z., & Gu, Y. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/32/325102 · Cited by 40 · see citing works

Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus

Tyler, M. A., Ulasov, I. V., Borovjagin, A. V., Sonabend, A. M., Khramtsov, A., Han, Y., Dent, P., Fisher, P. B., Curiel, D. T., & Lesniak, M. S. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0187 · Cited by 37 · see citing works

Pilot study on the interaction between B16 melanoma cell-line and bone-marrow derived mesenchymal stem cells

Sun, T., Sun, B., Ni, C., Zhao, X., Wang, X.-H., Qie, S., Zhang, D., Gu, Q., Qi, H., & Zhao, N. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.12.015 · Cited by 37 · see citing works

Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2

Roth, P., Hammer, C., Piguet, A., Ledermann, M., Dufour, J., & Waelti, E. R. (2007) · Journal of drug targeting · doi:10.1080/10611860701502723 · Cited by 29 · see citing works

Targeting human cancer cells with VEGF receptor-2-directed liposomes

Rubio Demirovic, A., Marty, C., Console, S., Zeisberger, S. M., Ruch, C., Jaussi, R., Schwendener, R., & Ballmer-Hofer, K. (2005) · PubMed · doi:10.5167/uzh-2971 · Cited by 21 · see citing works

Effects of taohong siwu decoction II in the chick chorioallantoic membrane (CAM) assay and on B16 melanoma in mice and endothelial cells ECV304 proliferation.

Xu, X., Wang, S., Chen, W., & Chen, G. (2006) · PubMed · Cited by 8 · see citing works

Smart nanoparticles for cancer therapy

Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073 · see citing works

Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review

Viegas, C., Patrício, A. B., Prata, J., Nadhman, A., Chintamaneni, P. K., & Fonte, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061593 · Cited by 565 · see citing works

Targeting receptor-mediated endocytotic pathways with nanoparticles: Rationale and advances

Xu, S., Olenyuk, B. Z., Okamoto, C. T., & Hamm‐Alvarez, S. F. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.041 · Cited by 469 · see citing works

Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review

Haider, M. A., Abdin, S. M., Kamal, L., & Orive, G. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030288 · Cited by 464 · see citing works

Nanostructured Lipid Carriers (NLCs) for Drug Delivery and Targeting

Fang, C.-L., Al‐Suwayeh, S. A., & Fang, J. (2012) · Recent Patents on Nanotechnology · doi:10.2174/187221013804484827 · Cited by 408 · see citing works

Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer

Yang, X., Li, Y., Li, M., Zhang, L., Feng, L., & Zhang, N. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.07.002 · Cited by 263 · see citing works

Microfluidic-assisted fabrication of carriers for controlled drug delivery

Liu, D., Zhang, H., Fontana, F., Hirvonen, J. J., & Santos, H. A. (2017) · Lab on a Chip · doi:10.1039/c7lc00242d · Cited by 255 · see citing works

The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles

Liu, C., Liu, F., Feng, L., Li, M., Zhang, J., & Zhang, N. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.038 · Cited by 168 · see citing works

Bioengineered cellular and cell membrane-derived vehicles for actively targeted drug delivery: So near and yet so far

Thanuja, M. Y., Anupama, C., & Ranganath, S. H. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.012 · Cited by 156 · see citing works

Surface modification of lipid-based nanocarriers for cancer cell-specific drug targeting

Kim, C. H., Lee, S. G., Kang, M. J., Lee, S. K., & Choi, Y. W. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0329-5 · Cited by 144 · see citing works

Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems

Dianat-Moghadam, H., Heidarifard, M., Jahanban-Esfahlan, R., Panahi, Y., Hamishehkar, H., Pouremamali, F., Rahbarghazi, R., & Nouri, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.043 · Cited by 140 · see citing works

Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic

Olerile, L. D., Liu, Y., Zhang, B., Wang, T., Mu, S., Zhang, J., Selotlegeng, L., & Zhang, N. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.11.032 · Cited by 140 · see citing works

Docetaxel Nanotechnology in Anticancer Therapy

Zhao, P., & Astruc, D. (2012) · ChemMedChem · doi:10.1002/cmdc.201200052 · Cited by 130 · see citing works

Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer

Liu, Y., Feng, L., Liu, T., Zhang, L., Yao, Y., Yu, D., Wang, L., & Zhang, N. (2014) · Nanoscale · doi:10.1039/c3nr05647c · Cited by 126 · see citing works

How nanotechnology can enhance docetaxel therapy

Zhang, L., & Zhang, N. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s46921 · Cited by 125 · see citing works

Fabrication of active targeting lipid nanoparticles: Challenges and perspectives

Menon, I., Zaroudi, M., Zhang, Y., Aisenbrey, E. A., & Hui, L. (2022) · Materials Today Advances · doi:10.1016/j.mtadv.2022.100299 · Cited by 124 · see citing works

Solid Lipid Nanoparticle Formulations of Docetaxel Prepared with High Melting Point Triglycerides: In Vitro and in Vivo Evaluation

Naguib, Y. W., Rodriguez, B. L., Li, X., Hursting, S. D., Williams, R. O., & Cui, Z. (2014) · Molecular Pharmaceutics · doi:10.1021/mp4006968 · Cited by 117 · see citing works

Developments in nanotechnology approaches for the treatment of solid tumors

Venturini, J., Chakraborty, A., Baysal, M. A., & Tsimberidou, A. M. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00656-1 · Cited by 117 · see citing works

Solid lipid-based nanocarriers as efficient targeted drug and gene delivery systems

Dolatabadi, J. E. N., & Omidi, Y. (2016) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2015.12.016 · Cited by 106 · see citing works

Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor

Li, X., Wu, M., Pan, L., & Shi, J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s81156 · Cited by 94 · see citing works

Targeted hyaluronic acid-based lipid nanoparticle for apigenin delivery to induce Nrf2-dependent apoptosis in lung cancer cells

Mahmoudi, S., Ghorbani, M., Sabzichi, M., Ramezani, F., Hamishehkar, H., & Samadi, N. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.11.013 · Cited by 90 · see citing works

Combination of nanotechnology with vascular targeting agents for effective cancer therapy

Jahanban‐Esfahlan, R., Seidi, K., Banimohamad‐Shotorbani, B., Jahanban‐Esfahlan, A., & Yousefi, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26051 · Cited by 84 · see citing works

Micro‐ and Nanotechnologies for Intracellular Delivery

Yan, L., Zhang, J., Lee, C., & Chen, X. (2014) · Small · doi:10.1002/smll.201401532 · Cited by 84 · see citing works

Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy

Marques, A. C., Costa, P. C., Velho, S., & Amaral, M. H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010216 · Cited by 84 · see citing works

Current development in nanoformulations of docetaxel

Tan, Q., Liu, X., Fu, X., Li, Q., Dou, J., & Zhai, G. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.696606 · Cited by 80 · see citing works

Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy

Zhang, N., Wang, & Li (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s32520 · Cited by 77 · see citing works

Galactose-Decorated Reduction-Sensitive Degradable Chimaeric Polymersomes as a Multifunctional Nanocarrier To Efficiently Chaperone Apoptotic Proteins into Hepatoma Cells

Wang, X., Sun, H., Meng, F., Cheng, R., Deng, C., & Zhong, Z. (2013) · Biomacromolecules · doi:10.1021/bm4007248 · Cited by 70 · see citing works

Surface engineering of nanomaterials with phospholipid-polyethylene glycol-derived functional conjugates for molecular imaging and targeted therapy

Zhang, D., & Zhang, J. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119646 · Cited by 65 · see citing works

Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance

Wang, L., & Jia, E. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1101792 · Cited by 63 · see citing works

Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application

Rizwanullah, M., Ahmad, M. Z., Garg, A., & Ahmad, J. (2021) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2021.129936 · Cited by 60 · see citing works

Surface-tailored anti-HER2/neu-solid lipid nanoparticles for site-specific targeting MCF-7 and BT-474 breast cancer cells

Souto, E. B., Doktorovová, S., Campos, J. R. S., Martins‐Lopes, P., & Silva, A. M. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.11.022 · Cited by 60 · see citing works

The enhanced longevity and liver targetability of Paclitaxel by hybrid liposomes encapsulating Paclitaxel-conjugated gold nanoparticles

Bao, Q., Zhang, N., Geng, D., Xue, J., Merritt, M., Zhang, C., & Ding, Y. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.10.040 · Cited by 58 · see citing works

For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy

Karimi, S., Bakhshali, R., Bolandi, S., Zahed, Z., Zadeh, S. S. M., Zenjanab, M. K., & Jahanban‐Esfahlan, R. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101626 · Cited by 60 · see citing works

Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel

Sun, B., Luo, C., Li, L., Wang, M., Du, Y., Di, D., Zhang, D., Ren, G., Pan, X., Fu, Q., et al. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.02.065 · Cited by 57 · see citing works

Application of Nanoparticles in the Treatment of Lung Cancer With Emphasis on Receptors

Wang, J., Zhou, T., Liu, Y., Chen, S., & Yu, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.781425 · Cited by 57 · see citing works

Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancer

Kim, J.-E., & Park, Y. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s124158 · Cited by 55 · see citing works

Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy

Zhang, G., Liu, F., Jia, E., Jia, L., & Zhang, Y. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1054052 · Cited by 51 · see citing works

Integrinβ6-Targeted Immunoliposomes Mediate Tumor-Specific Drug Delivery and Enhance Therapeutic Efficacy in Colon Carcinoma

Liang, B., Shahbaz, M., Wang, Y., Gao, H., Fang, R., Niu, Z., Liu, S., Wang, B., Sun, Q., Niu, W., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1194 · Cited by 51 · see citing works

Liposome surface modification by phospholipid chemical reactions

de Lima, P. H. C., Butera, A. P., Cabeça, L. F., & Ribeiro-Viana, R. (2021) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2021.105084 · Cited by 50 · see citing works

Development and characterization of gel-in-water nanoemulsion as a novel drug delivery system

Fardous, J., Omoso, Y., Joshi, A., Yoshida, K., Patwary, M. K. A., Ono, F., & Ijima, H. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112076 · Cited by 49 · see citing works

Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression

Filippo, L. D. D., Duarte, J. L., Azambuja, J. H., Mancuso, R. I., Luiz, M. T., Araújo, V. H. S., Figueiredo, I. D., Barretto‐de‐Souza, L., Sábio, R. M., Sasso‐Cerri, E., et al. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121682 · Cited by 49 · see citing works

Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody

Abdolahpour, S., Toliyat, T., Omidfar, K., Modjtahedi, H., Wong, A. J., Rasaee, M. J., Kashanian, S., & Paknejad, M. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1296847 · Cited by 45 · see citing works

Lipid-based Nanosystems for CD44 Targeting in Cancer Treatment: Recent Significant advances, Ongoing Challenges and Unmet Needs

Nascimento, T. L., Hillaireau, H., Vergnaud, J., & Fattal, E. (2016) · Nanomedicine · doi:10.2217/nnm-2016-5000 · Cited by 43 · see citing works

Synergistic Enhancement of Cancer Therapy Using a Combination of Ceramide and Docetaxel

Feng, L., Li, M., Liu, Y., Yang, S., & Zhang, N. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034201 · Cited by 42 · see citing works

Improved Antitumor Efficacy of Hyaluronic Acid-Complexed Paclitaxel Nanoemulsions in Treating Non-Small Cell Lung Cancer

Kim, J.-E., & Park, Y. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.261 · Cited by 41 · see citing works

Polymer-Mediated Penetration-Independent Cancer Therapy

Ding, J., Feng, X., Jiang, Z., Xu, W., Guo, H., Zhuang, X., & Chen, X. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b01263 · Cited by 41 · see citing works

RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells

Lee, S. G., Kim, C. H., Sung, S. W., Lee, E. S., Goh, M. S., Yoon, H. Y., Kang, M. J., Lee, S. K., & Choi, Y. W. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s166021 · Cited by 37 · see citing works

Gold Nanoparticles for Cancer Theranostics

Liang, H., Tian, H., Deng, M., & Chen, X. (2015) · Chinese Journal of Chemistry · doi:10.1002/cjoc.201500390 · Cited by 37 · see citing works

Monoclonal Antibodies Carried in Drug Delivery Nanosystems as a Strategy for Cancer Treatment

Silvestre, A. L. P., Oshiro, J. A., Garcia, C. M., Turco, B. O., Leite, J. M. D. S., Damasceno, B. P. G. D. L., Soares, J. C. M., & Chorilli, M. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200121121409 · Cited by 35 · see citing works

Formulation Design and Evaluation of Quantum Dot-Loaded Nanostructured Lipid Carriers for Integrating Bioimaging and Anticancer Therapy

Hsu, S.-H., Wen, C.-J., Al‐Suwayeh, S. A., Huang, Y., & Fang, J. (2013) · Nanomedicine · doi:10.2217/nnm.12.170 · Cited by 35 · see citing works

Electrochemical monitoring of an important biomarker and target protein: VEGFR2 in cell lysates

Wei, T., Tu, W., Zhao, B., Lan, Y., Bao, J., & Dai, Z. H. (2014) · Scientific Reports · doi:10.1038/srep03982 · Cited by 33 · see citing works

A novel small peptide as an epidermal growth factor receptor targeting ligand for nanodelivery in vitro

Pan, W., Han, C., Yue, L., Tai, L., Li, Z., Li, X., Xing, G., Yang, X., & Sun, L. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s43627 · Cited by 33 · see citing works

Polymeric complex micelles with double drug-loading strategies for folate-mediated paclitaxel delivery

Li, M., Liu, Y., Feng, L., Liu, F., Zhang, L., & Zhang, N. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.04.057 · Cited by 33 · see citing works

Lipid Drug Carriers for Cancer Therapeutics: An Insight into Lymphatic Targeting, P-gp, CYP3A4 Modulation and Bioavailability Enhancement

Chaturvedi, S., Verma, A. K., & Saharan, V. A. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2020.064 · Cited by 33 · see citing works

Brain targeted delivery of anticancer drugs: prospective approach using solid lipid nanoparticles

Anand, A., Sugumaran, A., & Narayanasamy, D. (2019) · IET Nanobiotechnology · doi:10.1049/iet-nbt.2018.5322 · Cited by 32 · see citing works

Antineoplastics Encapsulated in Nanostructured Lipid Carriers

da Silva, G. H. R., de Moura, L. D., de Carvalho, F. V., Gerônimo, G., Mendonça, T. C., de Lima, F. F., & de Paula, E. (2021) · Molecules · doi:10.3390/molecules26226929 · Cited by 32 · see citing works

Tumor-targeted hyaluronic acid-mPEG modified nanostructured lipid carriers for cantharidin delivery: An in vivo and in vitro study

Sun, S., Shang, E., Ju, A.-X., Li, Y., Wu, Q., Li, Q., Yang, Y., Guo, Y., Yang, D., & Lv, S. (2021) · Fitoterapia · doi:10.1016/j.fitote.2021.105033 · Cited by 26 · see citing works

Targeted Molecular Imaging Probes Based on Magnetic Resonance Imaging for Hepatocellular Carcinoma Diagnosis and Treatment

Zhao, D., Cao, J., Zhang, L., Zhang, S., & Wu, S. (2022) · Biosensors · doi:10.3390/bios12050342 · Cited by 26 · see citing works

Tumor-Specific Delivery and Therapy by Double-Targeted DTX-CMCS-PEG-NGR Conjugates

Liu, F., Li, M., Liu, C., Liu, Y., Liang, Y., Wang, F., & Zhang, N. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1176-3 · Cited by 26 · see citing works

Small peptide-modified nanostructured lipid carriers distribution and targeting to EGFR-overexpressing tumor in vivo

Han, C., Li, Y., Sun, M., Liu, C., Ma, X., Yang, X., Yuan, Y., & Pan, W. (2013) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2013.801848 · Cited by 24 · see citing works

A novel cationic nanostructured lipid carrier for improvement of ocular bioavailability: Design, optimization, in vitro and in vivo evaluation

Liu, R., Wang, S., Sun, L., Fang, S., Wang, J., Huang, X., You, Z., He, X., & Liu, C. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2016.03.009 · Cited by 23 · see citing works

Sterically Stabilized RIPL Peptide-Conjugated Nanostructured Lipid Carriers: Characterization, Cellular Uptake, Cytotoxicity, and Biodistribution

Kim, C. H., Sung, S. W., Lee, E. S., Kang, T. H., Yoon, H. Y., Goo, Y. T., Cho, H. R., Kim, D. Y., Kang, M. J., Choi, Y. S., et al. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040199 · Cited by 23 · see citing works

Co-delivery of doxorubicin and siRNA by a simplified platform with oligodeoxynucleotides as a drug carrier

Liu, T., Wang, M., Wang, T., Yao, Y., & Zhang, N. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.01.006 · Cited by 22 · see citing works

Sindbis Virus-Pseudotyped Lentiviral Vectors Carrying VEGFR2-Specific Nanobody for Potential Transductional Targeting of Tumor Vasculature

Ahani, R., Roohvand, F., Cohan, R. A., Etemadzadeh, M. H., Mohajel, N., Behdani, M., Shahosseini, Z., Madani, N., & Azadmanesh, K. (2016) · Molecular Biotechnology · doi:10.1007/s12033-016-9973-7 · Cited by 22 · see citing works

Low-toxicity FePt nanoparticles for the targeted and enhanced diagnosis of breast tumors using few centimeters deep whole-body photoacoustic imaging

Liu, Y., Wu, P., Guo, S., Chou, P., Deng, C., Chou, S., Yuan, Z., & Liu, T. (2020) · Photoacoustics · doi:10.1016/j.pacs.2020.100179 · Cited by 20 · see citing works

Subcellular drug targeting, pharmacokinetics and bioavailability

Leucuta, S. E. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.848453 · Cited by 20 · see citing works

Docetaxel-loaded nanoformulations delivery for breast cancer management: Challenges, recent advances, and future perspectives

Panthi, V. K., Bashyal, S., & Paudel, K. R. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105314 · Cited by 19 · see citing works

Mechanistic Studies on the Self-Assembly of PLGA Patchy Particles and Their Potential Applications in Biomedical Imaging

Salvador-Morales, C., Brahmbhatt, B., Márquez‐Miranda, V., Araya‐Durán, I., Canan, J., González-Nilo, F. D., Vilos, C., Cebral, J., Mut, F., Löhner, R., et al. (2016) · Langmuir · doi:10.1021/acs.langmuir.6b02177 · Cited by 19 · see citing works

Preparation and cellular targeting study of VEGF-conjugated PLGA nanoparticles

Shi, Y., Zhou, M., Zhang, J., & Lu, W. Z. (2015) · Journal of Microencapsulation · doi:10.3109/02652048.2015.1035683 · Cited by 18 · see citing works

Recent Advances and Strategies in Tumor Vasculature Targeted Nano-Drug Delivery Systems

Man, Y. M., Chen, G., & Lu, W. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150531163047 · Cited by 18 · see citing works

Use of intracellular transport processes for targeted drug delivery into a specified cellular compartment

Rosenkranz, A. A., Ulasov, A. V., Slastnikova, T. A., Khramtsov, Y. V., & Sobolev, A. S. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914090090 · Cited by 19 · see citing works

Design, synthesis, and evaluation of VEGFR-targeted macromolecular MRI contrast agent based on biotin–avidin-specific binding

Liu, Y., Wu, X., Sun, X., Wang, D., Zhong, Y., Jiang, D., Wang, T., Yu, D., & Zhang, N. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s131878 · Cited by 17 · see citing works

A Multifunctional Magnetic Composite Material as a Drug Delivery System and a Magnetic Resonance Contrast Agent

Zhang, G., Gao, J., Qian, J., Cai, D., Zheng, K., Yu, Z., Wang, J., Zhong, K., Zhang, X., & Wu, Z. (2014) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201300366 · Cited by 17 · see citing works

Combinatory antitumor therapy by cascade targeting of a single drug

Liu, A., Wang, H., Hou, X., Ma, Y., Yang, G., Hou, Y., & Ding, Y. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.08.011 · Cited by 17 · see citing works

Nanotechnology Meets the Tumor Microenvironment: Unlocking New Horizons in Cancer Therapy

Yadav, P., Yadav, A. K., & Bhatia, D. D. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c01120 · Cited by 16 · see citing works

The combination of MnO 2 @Lipo-coated gefitinib and bevacizumab inhibits the development of non-small cell lung cancer

Zhang, J., Xu, L. L., Hu, H., & Chen, E. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2032872 · Cited by 15 · see citing works

Surface Immobilization of Anti-VEGF Peptide on SPIONs for Antiangiogenic and Targeted Delivery of Paclitaxel in Non-Small-Cell Lung Carcinoma

Ngema, L. M., Adeyemi, S. A., Marimuthu, T., Ubanako, P. N., Ngwa, W. F., & Choonara, Y. E. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00224 · Cited by 15 · see citing works

Exploring the therapeutic potential of ligand-decorated nanostructured lipid carriers for targeted solid tumor therapy

Naz, Z., Fareed, M., Chaudhary, A. R. H., Snigdha, N. T., Zafar, A., Alsaidan, O. A., Mangu, K., Ahmad, S., Aslam, M., & Rizwanullah, M. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125687 · Cited by 14 · see citing works

Intracellular Protein Delivery System Using a Target-Specific Repebody and Translocation Domain of Bacterial Exotoxin

Kim, H.-Y., Kang, J. A., Ryou, J., Lee, G. H., Choi, D. S., Lee, D. E., & Kim, H. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00562 · Cited by 14 · see citing works

Liposomes as Drug Delivery Vehicles

Wang, G. (2016) · Drug Delivery · doi:10.1002/9781118833322.ch13 · Cited by 14 · see citing works

Application of nanoparticles to target tumor blood vessels as a promising cancer treatment strategy

Lorenc, P., Dams‐Kozlowska, H., Guzniczak, N., & Florczak, A. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118038 · Cited by 12 · see citing works

The Application of Nanotechnology in the Codelivery of Active Constituents of Plants and Chemotherapeutics for Overcoming Physiological Barriers during Antitumor Treatment

Li, Q., Xiong, Y., Ji, C., & Yan, Z. (2019) · BioMed Research International · doi:10.1155/2019/9083068 · Cited by 12 · see citing works

Nanosystem functionalization strategies for prostate cancer treatment: a review

de Araújo, J. T. C., Duarte, J. L., Filippo, L. D. D., Araújo, V. H. S., Carvalho, G. C., & Chorilli, M. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1892121 · Cited by 12 · see citing works

Nano-interventions for the drug delivery of docetaxel to cancer cells

Chaurawal, N., & Raza, K. (2023) · Health Sciences Review · doi:10.1016/j.hsr.2023.100101 · Cited by 12 · see citing works

Nanotherapeutic Platforms for Cancer Treatment: From Preclinical Development to Clinical Application

Egusquiaguirre, S. P., Pedraz, J. L., Hernández, R. M., & Igartua, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-47347-7.00029-x · Cited by 12 · see citing works

Construction of a two-in-one liposomal system (TWOLips) for tumor-targeted combination therapy

Su, T., Long, Y., Deng, C., Feng, L., Zhang, X., Chen, Z., & Li, C. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.09.055 · Cited by 9 · see citing works

Functional Moieties for Intracellular Traffic of Nanomaterials

Silva, A. L., Moura, L. I. F., Carreira, B., Conniot, J., Matos, A. I., Peres, C., Sainz, V., Silva, L. C., Gaspar, R. S., & Florindo, H. F. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-50878-0.00014-8 · Cited by 8 · see citing works

Nanobiotechnology and Nanostructured Therapeutic Delivery Systems

Castro, N. J., Umanzor‐Alvarez, J., Zhang, L. G., & Keidar, M. (2012) · Recent Patents on Biomedical Engineering · doi:10.2174/1874764711205010029 · Cited by 6 · see citing works

Anticancer Nanoparticle Carriers of the Proapoptotic Protein Cytochrome c

Zhivkov, A. M., Hristova, S. H., & Popov, T. T. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030305 · Cited by 5 · see citing works

Design of Nanostructured Lipid Carriers and Hybrid Lipid Nanoparticles

Berti, I. R., Singh, T., Boztepe, T., León, I. E., Nadda, A. K., & Castro, G. R. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781788019613-00381 · Cited by 5 · see citing works

Recent advances in polymer-based nanoparticles: current strategies and translational challenges in cancer therapy

Janakiraman, K., Sethuraman, V., Krishnaswami, V., & Sampath, G. (2025) · Journal of Chemotherapy · doi:10.1080/1120009x.2025.2573516 · Cited by 4 · see citing works

Advances in the systemic administration of nanotechnology-mediated drug delivery systems in melanoma treatment: a systematic review

Fereidouni, M., Roointanpour, Y., Movahed, H., Taghipour, A., Vafafar, A., & Jahromi, M. A. M. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-06998-z · Cited by 5 · see citing works

Nanostructured Lipid Carriers: A Novel Platform in the Formulation of Targeted Drug Delivery Systems

Putchakayala, N. S. D., Morusu, K., Ramisetty, S., & Ravoru, N. (2024) · Current Nanomedicine · doi:10.2174/0124681873283751240206071835 · Cited by 3 · see citing works

Preparation and the biodistribution study of [131I]-5,10,15,20-tetrakis(4-hydroxyphenyl)porphyrin and 5-(4-aminophenyl)-10,15,20-triphenylporphyrin

Sun, Z., Wei, H., Wang, G., Zhou, Z., He, J., Wang, J., & Luo, S. (2014) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-014-3269-9 · Cited by 3 · see citing works

SpyTag/SpyCatcher-ligated nanostructured lipid carriers for active mammary cancer targeting

Sung, M. K., Heo, J. Y., Jang, S., Kim, H., Jeong, Y., Lee, S.-J., Kim, S. T., & Kim, S. T. (2025) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2025.05.017 · Cited by 2 · see citing works

A Comprehensive Review of Nanostructured Lipid Carriers: Innovations and Applications in Breast Cancer Treatment

Mirajkar, P., Ahlawat, P., Patel, A., Patel, S., & Panjwani, D. (2024) · Recent Advances in Drug Delivery and Formulation · doi:10.2174/0126673878313086241031154146 · Cited by 2 · see citing works

Advancements in Nanostructured Smart Drug Delivery Systems in Cancer Treatment: Targeted Modification Strategies and Clinical Implications

Tripathi, A., Vaishnaw, B., Jaishwal, P., Samal, P. K., Verma, A., & Singh, N. (2025) · Current Materials Science · doi:10.2174/0126661454366845250618053301 · Cited by 2 · see citing works

Nanostructured Lipid Carrier (NLCs): Next Generation Lipid Nanocarriers for Breast Cancer Therapy

Rahman, M. U., Kausar, S., Razzaqe, S., Arshad, S., Shafqat, A., Sadiq, H., Erum, A., Hashmi, A. R., Shamim, A., Tahir, N., et al. (2026) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-025-00551-5 · Cited by 1 · see citing works

Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel

Liu, D., Liu, Z., Wang, L., Zhang, C., & Zhang, N. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.02.038 · Cited by 245 · see citing works

Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel B Biointerfaces

Liu, D., Liu, Z., Wang, L., Zhang, C., & Zhang, N. (2011) · Colloids and Surfaces

Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy

Orleth, A., Mamot, C., Rochlitz, C. F., Ritschard, R., Alitalo, K. K., Christofori, G., & WICKI, A. N. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1056189 · Cited by 25 · see citing works

Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody

Abdolahpour, S., Toliyat, T., Omidfar, K., Modjtahedi, H., Wong, A. J., Rasaee, M. J., Kashanian, S., & Paknejad, M. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1296847 · Cited by 45 · see citing works

Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy

Zhang, N., Wang, & Li (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s32520 · Cited by 77 · see citing works